Document is current
Any future updates will be listed below
-
Authors
Lin, Yu-Fen
Hu, Qing
Mazzagatti, Alice https://orcid.org/0000-0003-1627-0446
Valle-Inclán, Jose Espejo https://orcid.org/0000-0002-4857-5984
Maurais, Elizabeth G.
Dahiya, Rashmi
Guyer, Alison
Sanders, Jacob T.
Engel, Justin L. https://orcid.org/0000-0002-2016-3494
Nguyen, Giaochau
Bronder, Daniel https://orcid.org/0000-0003-1666-2896
Bakhoum, Samuel F.
Cortés-Ciriano, Isidro https://orcid.org/0000-0002-2036-494X
Ly, Peter https://orcid.org/0000-0001-8946-7069
- License Information
-
More Information
Article History
Received: 19 July 2022
Accepted: 17 March 2023
First Online: 10 May 2023
Competing interests
: S.F.B. owns equity in, receives compensation from and serves as a consultant and on the scientific advisory board and board of directors of Volastra Therapeutics. The other authors declare no competing interests.
